Celiprolol is a beta-blocker medicine that was introduced in 1982. It is mainly used in the treatment of high blood pressure (hypertension) and certain cardiovascular conditions. The drug works by blocking beta-1 receptors in the heart, which helps reduce heart rate and the force of heart contractions, thereby lowering blood pressure and decreasing the workload on the heart. Unlike some other beta-blockers, celiprolol also has mild beta-2 stimulating activity, which may help improve blood vessel relaxation and reduce some breathing-related side effects.
BRAND NAMES
Cardem
Selectol
Celipres / Celipress
Celipro
Celol
Cordiax
MECHANISM OF ACTION
Celiprolol works as a selective beta-blocker. It mainly blocks β1-adrenergic receptors in the heart, which reduces heart rate, decreases the force of contraction, and lowers cardiac output—leading to reduced blood pressure. At the same time, it has partial β2-agonist activity, which can cause mild vasodilation (relaxation of blood vessels) and may reduce bronchoconstriction compared to non-selective beta-blockers.
PHARMACOKINETICS
Absorption
Celiprolol is moderately absorbed after oral administration. Its bioavailability is about 30–50%, and it is absorbed mainly in the small intestine. Food can slightly reduce or delay its absorption.
Ditribution
Celiprolol is moderately distributed in the body, with relatively low protein binding (about 25–30%). It does not easily cross the blood–brain barrier, so central nervous system effects are limited. It is distributed mainly in extracellular fluids.
Metabolism
Celiprolol is minimally metabolized in the liver. Most of the drug remains unchanged in the body and is primarily excreted through the kidneys, which reduces the likelihood of significant drug interactions.
Excretion
Celiprolol is mainly eliminated unchanged in the urine via the kidneys. About 70–80% of the administered dose is excreted in urine within 24 hours, with a half-life of 8–10 hours, allowing for once- or twice-daily dosing.
PHARMACODYNAMICS
Celiprolol is a β₁-selective blocker with β₂ agonist activity that slows the heart, reduces contraction force, and lowers blood pressure, while mild vasodilation helps maintain blood flow and reduce side effects.
Administration
Celiprolol is given orally (by mouth) in tablet form. It is usually taken once or twice daily, preferably at the same time each day, as prescribed by a doctor. It should be taken regularly for best control of blood pressure and not stopped suddenly without medical advice.
Dosage and Strength
Adults: Typically start with 200 mg once daily in the morning.
DRUG INTERACTIONS
FOOD INTERACTIONS
Celiprolol can be taken with or without food, as food does not significantly affect its absorption or effectiveness. However, alcohol should be limited, as it may increase blood pressure-lowering effects and cause dizziness or fainting. Grapefruit juice does not have a major impact on celiprolol.
CONTRAINDICATIONS
Celiprolol is contraindicated in patients with severe asthma orbronchospasm, bradycardia, heart block, severe heart failure, or very low blood pressure. It should also be avoided in individuals with a known allergy to celiprolol or other beta-blockers, and caution is required in those with severe kidney or liver impairment, as the drug may accumulate and cause adverse effects.
SIDE EFFECTS
Dizziness and headache
Fatigue and sleep disturbances
Nausea and dry mouth
Cold hands or feet
Slow heartbeat (bradycardia)
Shortness of breath (rare)
Mood changes or depression (rare)
Erectile dysfunction (rare)
OVER DOSE
Severe low blood pressure (hypotension)
Extremely slow heart rate (bradycardia)
Heart block or cardiac shock
Dizziness, fainting, fatigue
Shortness of breath
TOXICITY
Toxicity occurs mainly in overdose and results from excessive β-blockade. It can cause severe bradycardia, hypotension, dizziness, bronchospasm, and heart failure, and in extreme cases may lead to shock or cardiac arrest. Treatment is supportive and requires urgent medical care.